Asarina Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Asarina Pharma has a total shareholder equity of SEK1.6M and total debt of SEK1,000.0K, which brings its debt-to-equity ratio to 64%. Its total assets and total liabilities are SEK6.0M and SEK4.4M respectively.
Key information
64.0%
Debt to equity ratio
kr1.00m
Debt
Interest coverage ratio | n/a |
Cash | kr3.16m |
Equity | kr1.56m |
Total liabilities | kr4.43m |
Total assets | kr5.99m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ASAP's short term assets (SEK5.2M) exceed its short term liabilities (SEK3.4M).
Long Term Liabilities: ASAP's short term assets (SEK5.2M) exceed its long term liabilities (SEK999.0K).
Debt to Equity History and Analysis
Debt Level: ASAP has more cash than its total debt.
Reducing Debt: ASAP's debt to equity ratio has increased from 0% to 64% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ASAP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ASAP has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.2% each year.